Новости за 11.09.2016

The marijuana market is growing, but options are limited for investors who want established companies that don't trade on the pink sheets.

After rallying more than 900% over the past ten years, where will the tech giants stock head over the next decade?

Residents in one state are facing a weighted average rate hike of 59% in 2017.

Could a revived An-225 air freighter steal sales (and profits) from Boeing? We'll find out.

Years of falling revenue have been recently offset by investors' optimism for new segments like virtual reality -- and the stock is on a tear.

You don't have to read Mandarin to find companies well-positioned to profit from China's ongoing boom. Here are three familiar American names that fit the bill.

Shares of Chili's parent company traded up on impressive earnings growth in its fiscal fourth quarter report.

One of the more surprising parts of the S&P 500s resurgence in 2016 has been the group of stocks leading the charge to new all-time highs.

According to the pundits, the personal computing giant should be little more than an afterthought for investors.

Here are three potential risks to this chip giant's business.

Stronger-than-expected earnings helped Dick's Sporting Goods last month, but there could be questions ahead.

But last week's disaster in Florida could leave SpaceX still mostly unscathed.

A rough summer gets harder after a tourist was shot in Orlando, well off Disney's property but still a problematic development.

Up to 15 million people may qualify to take advantage of these smart retirement options.

The world's most popular racing series will soon be a public company for investors to buy into, but under the control of Liberty Media.

The 2003 Medicare Modernization Act bars the program from negotiating its own drug prices, and it's costing seniors a fortune in the process.

The third quarter was going to be a tough comparison for Ford anyways, but it just got even tougher.

Keep your eyes on the skies -- commercial drones are going mainstream, unleashing a fleet of new opportunities.

This Fool finds a couple of disappointments in Apple's new iPhones, particularly in the displays.

Revealing the difference between small-molecule drugs and biologics and illustrating why cash and equivalents is the most important line item on biotech balance sheets.

This Fool tries to discover what graphics processor is inside Apple's A10 Fusion chip.

The Tesla and SpaceX founder is single-handedly transforming industries through a mixture of genius ideas and new innovations -- and some of his quotes over the years explain how he's making it happen.

Why Oracle, Cracker Barrel, and United Natural Foods could make big moves over the next few trading days.

Growth is slowing down for the cybersecurity company. Investors didn't take the news well.